We are live on ! Find out more
AP

AHL Partners Portfolio holdings

AUM $6.41B
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+23.14%
3 Year Est. Return
+67.81%
5 Year Est. Return
10 Year Est. Return
AUM
$6.41B
AUM Growth
+$816M
Cap. Flow
+$472M
Cap. Flow %
7.36%
Top 10 Hldgs %
8.58%
Holding
1,445
New
224
Increased
492
Reduced
519
Closed
207

Sector Composition

1 Industrials 20.95%
2 Consumer Discretionary 19.04%
3 Financials 10.98%
4 Technology 9.04%
5 Healthcare 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIVO
1401
DELISTED
Meridian Bioscience Inc
VIVO
-34,361
Closed -$491K
CLVS
1402
DELISTED
Clovis Oncology, Inc.
CLVS
-16,707
Closed -$1.38M
AERI
1403
DELISTED
Aerie Pharmaceuticals
AERI
-6,932
Closed -$337K
NTUS
1404
DELISTED
Natus Medical Inc
NTUS
-38,473
Closed -$1.44M
MIME
1405
DELISTED
Mimecast Limited
MIME
-14,798
Closed -$421K
GTS
1406
DELISTED
Triple-S Management Corporation
GTS
-23,882
Closed -$538K
INOV
1407
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-28,914
Closed -$493K
CLDR
1408
DELISTED
Cloudera, Inc.
CLDR
-25,410
Closed -$423K
USCR
1409
DELISTED
U S Concrete, Inc.
USCR
-3,763
Closed -$287K
ARA
1410
DELISTED
American Renal Associates Holdings, Inc
ARA
-33,876
Closed -$507K
PTLA
1411
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-7,083
Closed -$383K
AXE
1412
DELISTED
Anixter International Inc
AXE
-20,674
Closed -$1.76M
PGNX
1413
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-19,919
Closed -$147K
MLNX
1414
DELISTED
Mellanox Technologies, Ltd.
MLNX
-4,275
Closed -$202K
PEGI
1415
DELISTED
Pattern Energy Group Inc. Class A
PEGI
-386,815
Closed -$9.32M
AKS
1416
DELISTED
AK Steel Holding Corp
AKS
-85,012
Closed -$475K
DPLO
1417
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-19,951
Closed -$413K
CBM
1418
DELISTED
Cambrex Corporation
CBM
-57,107
Closed -$3.14M
RTEC
1419
DELISTED
Rudolph Technologies Inc
RTEC
-15,562
Closed -$409K
TOWR
1420
DELISTED
Tower International, Inc.
TOWR
-18,428
Closed -$501K
CRAY
1421
DELISTED
Cray, Inc.
CRAY
-12,670
Closed -$246K
ARRY
1422
DELISTED
Array Biopharma Inc
ARRY
-71,293
Closed -$876K
LEXEA
1423
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-19,720
Closed -$1.05M
INSY
1424
DELISTED
Insys Therapeutics, Inc.
INSY
-15,622
Closed -$139K
HZNP
1425
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-106,405
Closed -$1.35M

Similar funds

AHL Partners's Q4 2017 Portfolio in Review

As of Q4 2017, AHL Partners held 1,445 positions worth $6.41B, up 15% from $5.59B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

AHL Partners deployed $472M of net new capital in Q4 2017, opening 224 new positions and adding to 492 existing holdings. Its largest new stake was Terminix Global Holdings, Inc.: 553,152 shares worth $19M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $26.8M trimmed.

  • AHL Partners's largest Q4 2017 buy was Terminix Global Holdings, Inc.: 553,152 shares worth $19M.
  • AHL Partners added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2017, an estimated $26.1M increase.
  • AHL Partners's biggest Q4 2017 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $26.8M.
  • AHL Partners fully exited Pattern Energy Group Inc. Class A in Q4 2017, selling an estimated $9.32M.
  • AHL Partners's ten largest holdings make up 8.6% of its $6.41B portfolio in Q4 2017.
  • AHL Partners opened 224 new positions and closed 207 in Q4 2017.
  • AHL Partners's portfolio value rose 15% quarter-over-quarter to $6.41B.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.